Cyclin D1 determines estrogen signaling in the mammary gland in vivo.

Abstract

The CCND1 gene, which is frequently overexpressed in cancers, encodes the regulatory subunit of a holoenzyme that phosphorylates the retinoblastoma protein. Although it is known that cyclin D1 regulates estrogen receptor (ER)α transactivation using heterologous reporter systems, the in vivo biological significance of cyclin D1 to estrogen-dependent signaling, and the molecular mechanisms by which cyclin D1 is involved, are yet to be elucidated. Herein, genome-wide expression profiling conducted of 17β-estradiol-treated castrated virgin mice deleted of the Ccnd1 gene demonstrated that cyclin D1 determines estrogen-dependent gene expression for 88% of estrogen-responsive genes in vivo. In addition, expression profiling of 17β-estradiol-stimulated cyclin D1 small interfering RNA treated MCF7 cells shows cyclin D1 is required for estrogen-mediated gene expression in vitro. Genome-wide chromatin immunoprecipitation-Seq analysis revealed a cyclin D1-DNA bound form associated with genes that were regulated by estrogen in a cyclin D1-dependent manner. The cyclin D1-dependent estrogen signaling pathways identified in vivo were highly enriched for extracellular membrane-associated growth factor receptors (epidermal growth factor receptor, ErbB3, and EphB3) and their ligands (amphiregulin, encoded by AREG gene), and matrix metalloproteinase. The AREG protein, a pivotal ligand for epidermal growth factor receptors to promote cellular proliferation, was induced by cyclin D1 via the AREG promoter. Chromatin immunoprecipitation analysis demonstrated the recruitment of cyclin D1 to the breast cancer 1 (Brca1)/ERα binding site of the Areg gene. Cyclin D1 genetic deletion demonstrated the in vivo requirement for cyclin D1 in assembling the estrogen-dependent amplified in breast cancer 1-associated multiprotein complex. The current studies define a requirement for cyclin D1 in estrogen-dependent signaling modules governing growth factor receptor and ligand expression in vivo and reveal a noncanonical function of cyclin D1 at ERα target gene promoters. Cyclin D1 mediates the convergence of ERα and growth factor signaling at a common cis-element of growth factor genes.

• Authors: Mathew C Casimiro, Chenguang Wang, Zhiping Li, Gabriele Di Sante, Nicole E Willmart, Sankar Addya, Lei Chen, Yang Liu, Michael P Lisanti, Richard G Pestell
• Journal: Molecular endocrinology (Baltimore, Md.) (Mol Endocrinol) Vol. 27 Issue 9 Pg. 1415-28 (Sep 2013) ISSN: 1944-9917 [Electronic] United States
• PMID: 23864650 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)

Chemical References

• AREG protein, human
• Amphiregulin
• Areg protein, mouse
• BRCA1 Protein
• Chromatin
• EGF Family of Proteins
• Estrogen Receptor alpha
• Estrogens
• Glycoproteins
• Intercellular Signaling Peptides and Proteins
• Cyclin D1
• Estradiol
• Matrix Metalloproteinases

Topics

• Amphiregulin
• Animals
• BRCA1 Protein (metabolism)
• Base Sequence
• Cell Proliferation (drug effects)
• Chromatin (metabolism)
• Cyclin D1 (metabolism)
• EGF Family of Proteins
• Epithelial Cells (cytology, drug effects, metabolism)
• Estradiol (pharmacology)
• Estrogen Receptor alpha (metabolism)
• Estrogens (metabolism)
• Female
• Gene Expression Regulation (drug effects)
• Genome, Human (genetics)
• Glycoproteins (metabolism)
• Humans
• Intercellular Signaling Peptides and Proteins (metabolism)
• MCF-7 Cells
• Mammary Glands, Animal (cytology, metabolism)
• Mammary Glands, Human (cytology, metabolism)
• Matrix Metalloproteinases (metabolism)
• Mice
• Molecular Sequence Data
• Molecular Weight
• Protein Binding (drug effects)
• Signal Transduction (drug effects)